Morgan Lewis

Related Publications

01/26/12 Panelist, Beyond Plain Vanilla in Consent Orders, presented for the American Bar Association Health Care and Pharmaceuticals Committee, Joint Conduct Committee
12/21/11 HSR Act Guidance for CEOs, Board Directors, and General Counsel
Unlike so-called "merger control" laws in most countries, the U.S. HSR Act applies to individual executive officers and directors acquiring shares of the employing corporation as part of their compensation if certain jurisdictional thresholds are satisfied.
12/01/11 FTC/DOJ Final Policy Statement on Accountable Care Organizations: Important Antitrust Issues Remain Unanswered, BNA's Health Law Reporter
View all publications

Related News

07/28/11 Morgan Lewis Advises Perrigo on FTC Approval of Paddock Acquisition
Morgan Lewis advised Perrigo on the closing of its acquisition of substantially all the assets of Paddock Laboratories, a transaction valued at approximately $540 million in cash.
01/26/10 Morgan Lewis Advises Better Place on $350 Million Financing
Better Place this week announced that it has signed an agreement with an HSBC-led investor consortium for new equity financing of $350 million.
10/15/09 Morgan Lewis Advises Pfizer on FTC Approval of $68 Billion Wyeth Acquisition and Related Litigation
The FTC has voted unanimously to approve Pfizer's acquisition of Wyeth.
View all news
Photo of David R. Brenneman

practice areas

bar admissions

  • District of Columbia
  • New York
print profile

David R. Brenneman
Associate

v-card

Email: dbrenneman@morganlewis.com
Washington, D.C.
1111 Pennsylvania Ave., NW
Washington, DC 20004-2541
Phone: 202.739.5056
Fax: 202.739.3001

David R. Brenneman is an associate in Morgan Lewis's Antitrust Practice. Mr. Brenneman represents clients in a wide range of antitrust matters, with a focus on mergers, acquisitions, joint ventures, and civil antitrust litigation. He has experience in every aspect of the merger process, including premerger notification under the Hart-Scott-Rodino (HSR) Act, international merger control, merger investigations, Second Requests, and compliance with consent orders.

Mr. Brenneman has represented clients before the Federal Trade Commission and the Department of Justice, prepared dozens of HSR filings, and coordinated competition filings around the world for multimillion- and billion-dollar transactions. He has represented clients in significant antitrust matters in the pharmaceutical, chemical, retail, and financial services industries, among others.

Mr. Brenneman earned his J.D. from Georgetown University Law Center in 2008 and his B.A. from the University of Maryland, College Park in 2005.

Mr. Brenneman is admitted to practice in the District of Columbia and New York.

education

  • Georgetown University Law Center, 2008, J.D.
  • University of Maryland, College Park, 2005, B.A.